Skip to main content
Erschienen in: Reviews in Endocrine and Metabolic Disorders 2/2021

26.03.2021

Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis

verfasst von: Zuleyha Karaca, Ashley Grossman, Fahrettin Kelestimur

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

The hypothalamo-pituitary-adrenal (HPA) axis is one of the main components of the stress system. Maintenance of normal physiological events, which include stress responses to internal or external stimuli in the body, depends on appropriate HPA axis function. In the case of severe cortisol deficiency, especially when there is a triggering factor, the patient may develop a life-threatening adrenal crisis which may result in death unless early diagnosis and adequate treatment are carried out. The maintenance of normal physiology and survival depend upon a sufficient level of cortisol in the circulation. Life-long glucocorticoid replacement therapy, in most cases meeting but not exceeding the need of the patient, is essential for normal life expectancy and maintenance of the quality of life. To enable this, the initial step should be the correct diagnosis of adrenal insufficiency (AI) which requires careful evaluation of the HPA axis, a highly dynamic endocrine system. The diagnosis of AI in patients with frank manifestations is not challenging. These patients do not need dynamic tests, and basal cortisol is usually enough to give a correct diagnosis. However, most cases of secondary adrenal insufficiency (SAI) take place in a gray zone when clinical manifestations are mild. In this situation, more complicated methods that can simulate the response of the HPA axis to a major stress are required. Numerous studies in the assessment of HPA axis have been published in the world literature. In this review, the tests used in the diagnosis of secondary AI or in the investigation of suspected HPA axis insufficiency are discussed in detail, and in the light of this, various recommendations are made.
Literatur
1.
Zurück zum Zitat Thomas A. On the constitutional and local effects of disease of the supra-renal capsules. In: London: Samuel Highley of 32 Fleet Street London. First ed; 1855. Thomas A. On the constitutional and local effects of disease of the supra-renal capsules. In: London: Samuel Highley of 32 Fleet Street London. First ed; 1855.
2.
Zurück zum Zitat Kline GA, Holmes DT. De-evolution of diagnostic testing for adrenal insufficiency. Lancet Diabetes & Endocrinol. 2017;5(2):88–90.CrossRef Kline GA, Holmes DT. De-evolution of diagnostic testing for adrenal insufficiency. Lancet Diabetes & Endocrinol. 2017;5(2):88–90.CrossRef
3.
Zurück zum Zitat De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19(3):269–301.PubMed De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 1998;19(3):269–301.PubMed
4.
Zurück zum Zitat Seoane L.M.T.S, Dieguez C. Hypothalamic-pituitary diseases endocrinology. Casanueva F. GE, editor: Springer, Cham; 2018. Seoane L.M.T.S, Dieguez C. Hypothalamic-pituitary diseases endocrinology. Casanueva F. GE, editor: Springer, Cham; 2018.
5.
Zurück zum Zitat Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403–16.PubMedPubMedCentralCrossRef Gjerstad JK, Lightman SL, Spiga F. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility. Stress. 2018;21(5):403–16.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Keller-Wood M. Hypothalamic-pituitary–adrenal Axis-feedback control. Compr Physi. 2015;5(3):1161–82.CrossRef Keller-Wood M. Hypothalamic-pituitary–adrenal Axis-feedback control. Compr Physi. 2015;5(3):1161–82.CrossRef
7.
Zurück zum Zitat Drury PL, Besser GM. Adrenal cortex. In: Reginald BGM, editor. Fundamentals of clinical endocrinology. Fourth ed. New York: Churchill Livingstone; 1989. Drury PL, Besser GM. Adrenal cortex. In: Reginald BGM, editor. Fundamentals of clinical endocrinology. Fourth ed. New York: Churchill Livingstone; 1989.
8.
Zurück zum Zitat Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, et al. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test? Eur J Endocrinol. 2003;149(6):535–41.PubMedCrossRef Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, et al. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test? Eur J Endocrinol. 2003;149(6):535–41.PubMedCrossRef
9.
Zurück zum Zitat Plumpton FS, Besser GM. The adrenocortical response to surgery and insulin-induced hypoglycaemia in corticosteroid-treated and normal subjects. Br J Surg. 1969;56(3):216–9.PubMedCrossRef Plumpton FS, Besser GM. The adrenocortical response to surgery and insulin-induced hypoglycaemia in corticosteroid-treated and normal subjects. Br J Surg. 1969;56(3):216–9.PubMedCrossRef
10.
Zurück zum Zitat Khoo B, Boshier PR, Freethy A, Tharakan G, Saeed S, Hill N, et al. Redefining the stress cortisol response to surgery. Clin Endocrinol. 2017;87(5):451–8.CrossRef Khoo B, Boshier PR, Freethy A, Tharakan G, Saeed S, Hill N, et al. Redefining the stress cortisol response to surgery. Clin Endocrinol. 2017;87(5):451–8.CrossRef
11.
Zurück zum Zitat Prete A, Yan Q. The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clin Endocrinol. 2018;89(5):554–67.CrossRef Prete A, Yan Q. The cortisol stress response induced by surgery: A systematic review and meta-analysis. Clin Endocrinol. 2018;89(5):554–67.CrossRef
12.
Zurück zum Zitat Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol. 1998;49(3):287–92.CrossRef Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol. 1998;49(3):287–92.CrossRef
13.
Zurück zum Zitat Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche diagnostics Elecsys(®) cortisol II assay. Ann Endocrinol. 2016;77(5):620–2.CrossRef Raverot V, Richet C, Morel Y, Raverot G, Borson-Chazot F. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche diagnostics Elecsys(®) cortisol II assay. Ann Endocrinol. 2016;77(5):620–2.CrossRef
14.
Zurück zum Zitat El-Farhan N, Pickett A, Ducroq D, Bailey C, Mitchem K, Morgan N, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol. 2013;78(5):673–80.CrossRef El-Farhan N, Pickett A, Ducroq D, Bailey C, Mitchem K, Morgan N, et al. Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays. Clin Endocrinol. 2013;78(5):673–80.CrossRef
15.
Zurück zum Zitat Ueland GA, Methlie P, Oksnes M, Thordarson HB, Sagen J, Kellmann R, et al. The short Cosyntropin test revisited: new Normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696–703.PubMedCrossRef Ueland GA, Methlie P, Oksnes M, Thordarson HB, Sagen J, Kellmann R, et al. The short Cosyntropin test revisited: new Normal reference range using LC-MS/MS. J Clin Endocrinol Metab. 2018;103(4):1696–703.PubMedCrossRef
16.
Zurück zum Zitat Brown S, Hadlow N, Badshah I, Henley D. A time-adjusted cortisol cut-off can reduce referral rate for Synacthen stimulation test whilst maintaining diagnostic performance. Clin Endocrinol. 2017;87(5):418–424. Brown S, Hadlow N, Badshah I, Henley D. A time-adjusted cortisol cut-off can reduce referral rate for Synacthen stimulation test whilst maintaining diagnostic performance. Clin Endocrinol. 2017;87(5):418–424.
17.
Zurück zum Zitat Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. Clin Endocrinol. 2003;88(9):4193–8.CrossRef Schmidt IL, Lahner H, Mann K, Petersenn S. Diagnosis of adrenal insufficiency: evaluation of the corticotropin-releasing hormone test and basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease. Clin Endocrinol. 2003;88(9):4193–8.CrossRef
18.
Zurück zum Zitat Karaca Z, Tanriverdi F, Atmaca H, Gokce C, Elbuken G, Selcuklu A, et al. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamicpituitary-adrenal axis before and after pituitary surgery? Eur J Endocrinol. 2010;163(3):377–82.PubMedCrossRef Karaca Z, Tanriverdi F, Atmaca H, Gokce C, Elbuken G, Selcuklu A, et al. Can basal cortisol measurement be an alternative to the insulin tolerance test in the assessment of the hypothalamicpituitary-adrenal axis before and after pituitary surgery? Eur J Endocrinol. 2010;163(3):377–82.PubMedCrossRef
19.
Zurück zum Zitat Yo WS, Toh LM, Brown SJ, Howe WD, Henley DE, Lim EM. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation? Clin Endocrinol. 2014;81(1):19–24.CrossRef Yo WS, Toh LM, Brown SJ, Howe WD, Henley DE, Lim EM. How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation? Clin Endocrinol. 2014;81(1):19–24.CrossRef
20.
Zurück zum Zitat Ortiz-Flores AE, Santacruz E, Jimenez-Mendiguchia L, Garcia-Cano A, Nattero-Chavez L, Escobar-Morreale HF, et al. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review. BMJ Open. 2018;8(5):e019273.PubMedPubMedCentralCrossRef Ortiz-Flores AE, Santacruz E, Jimenez-Mendiguchia L, Garcia-Cano A, Nattero-Chavez L, Escobar-Morreale HF, et al. Role of sampling times and serum cortisol cut-off concentrations on the routine assessment of adrenal function using the standard cosyntropin test in an academic hospital from Spain: a retrospective chart review. BMJ Open. 2018;8(5):e019273.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Varadhan L, Nayak AU, Mukherjee A, Jose B, Varughese GI. Can a baseline morning cortisol predict outcome of short Synacthen test in an endocrine unit in an outpatient setting. Clin Endocrinol. 2015;82(2):309–11. Varadhan L, Nayak AU, Mukherjee A, Jose B, Varughese GI. Can a baseline morning cortisol predict outcome of short Synacthen test in an endocrine unit in an outpatient setting. Clin Endocrinol. 2015;82(2):309–11.
22.
Zurück zum Zitat Manosroi W, Phimphilai M, Khorana J, Atthakomol P. Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency. PLoS One. 2019;14(11):e0225255.PubMedPubMedCentralCrossRef Manosroi W, Phimphilai M, Khorana J, Atthakomol P. Diagnostic performance of basal cortisol level at 0900-1300h in adrenal insufficiency. PLoS One. 2019;14(11):e0225255.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, et al. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol. 2017;86(2):177–84.CrossRef Sbardella E, Isidori AM, Woods CP, Argese N, Tomlinson JW, Shine B, et al. Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays. Clin Endocrinol. 2017;86(2):177–84.CrossRef
24.
Zurück zum Zitat Munro V, Tugwell B, Doucette S, Clarke DB, Lacroix A, Imran SA. Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism. Clin Endocrinol. 2016;85(2):216–22.CrossRef Munro V, Tugwell B, Doucette S, Clarke DB, Lacroix A, Imran SA. Recovery of adrenal function after chronic secondary adrenal insufficiency in patients with hypopituitarism. Clin Endocrinol. 2016;85(2):216–22.CrossRef
25.
Zurück zum Zitat Polovina TS, Kraljevic I, Solak M, Balasko A, Haxhiu A, Haxhiu A, et al. Early basal cortisol level as a predictor of Hypothalamic-Pituitary-Adrenal (HPA) axis function after pituitary tumor surgery. Exp Clin Endocrinol Diabetes. 2019;128(11):709–14.PubMed Polovina TS, Kraljevic I, Solak M, Balasko A, Haxhiu A, Haxhiu A, et al. Early basal cortisol level as a predictor of Hypothalamic-Pituitary-Adrenal (HPA) axis function after pituitary tumor surgery. Exp Clin Endocrinol Diabetes. 2019;128(11):709–14.PubMed
26.
Zurück zum Zitat Leong SH, Shander S, Ratnasingam J. Predicting recovery of the hypothalamic-pituitary-adrenal axis after prolonged glucocorticoid use. Endocrine. 2018;24(1):14–20. Leong SH, Shander S, Ratnasingam J. Predicting recovery of the hypothalamic-pituitary-adrenal axis after prolonged glucocorticoid use. Endocrine. 2018;24(1):14–20.
27.
Zurück zum Zitat Peechakara S, Bena J, Clarke NJ, McPhaul MJ, Reitz RE, Weil RJ, et al. Total and free cortisol levels during 1 µg, 25 µg, and 250 µg cosyntropin stimulation tests compared to insulin tolerance test: results of a randomized, prospective, pilot study. Endocrine. 2017;57(3):388–93. Peechakara S, Bena J, Clarke NJ, McPhaul MJ, Reitz RE, Weil RJ, et al. Total and free cortisol levels during 1 µg, 25 µg, and 250 µg cosyntropin stimulation tests compared to insulin tolerance test: results of a randomized, prospective, pilot study. Endocrine. 2017;57(3):388–93.
28.
Zurück zum Zitat Rauschecker M, Abraham SB, Abel BS, Wesley R, Saverino E, Trivedi A, et al. Cosyntropin-stimulated serum free cortisol in healthy, Adrenally insufficient, and mildly cirrhotic populations. J Clin Endocrinol Metab. 2016;101(3):1075–81.PubMedCrossRef Rauschecker M, Abraham SB, Abel BS, Wesley R, Saverino E, Trivedi A, et al. Cosyntropin-stimulated serum free cortisol in healthy, Adrenally insufficient, and mildly cirrhotic populations. J Clin Endocrinol Metab. 2016;101(3):1075–81.PubMedCrossRef
29.
Zurück zum Zitat Bancos I, Erickson D, Bryant S, Hines J, Nippoldt TB, Natt N, et al. Performance of free versus total cortisol following COSYNTROPIN stimulation testing in an outpatient setting. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2015;21(12):1353–63.CrossRef Bancos I, Erickson D, Bryant S, Hines J, Nippoldt TB, Natt N, et al. Performance of free versus total cortisol following COSYNTROPIN stimulation testing in an outpatient setting. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 2015;21(12):1353–63.CrossRef
30.
Zurück zum Zitat Turpeinen U, Hamalainen E. Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab. 2013;27(6):795–801.PubMedCrossRef Turpeinen U, Hamalainen E. Determination of cortisol in serum, saliva and urine. Best Pract Res Clin Endocrinol Metab. 2013;27(6):795–801.PubMedCrossRef
31.
Zurück zum Zitat Oelkers W, Boelke T, Bahr V. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. J Clin Endocrinol Metab. 1988;66(1):181–6.PubMedCrossRef Oelkers W, Boelke T, Bahr V. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. J Clin Endocrinol Metab. 1988;66(1):181–6.PubMedCrossRef
32.
Zurück zum Zitat Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol. 1987;26(2):221–6.CrossRef Hagg E, Asplund K, Lithner F. Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency. Clin Endocrinol. 1987;26(2):221–6.CrossRef
33.
Zurück zum Zitat Jenkins D, Forsham PH, Laidlaw JC, Reddy WJ, Thorn GW. Use of ACTH in the diagnosis of adrenal cortical insufficiency. Am J Med. 1955;18(1):3–14. Jenkins D, Forsham PH, Laidlaw JC, Reddy WJ, Thorn GW. Use of ACTH in the diagnosis of adrenal cortical insufficiency. Am J Med. 1955;18(1):3–14.
34.
Zurück zum Zitat Lee MK, Vasikaran S, Doery JC, Wijeratne N, Prentice D. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study. Postgrad Med J. 2013;89(1057):617–20.PubMedCrossRef Lee MK, Vasikaran S, Doery JC, Wijeratne N, Prentice D. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study. Postgrad Med J. 2013;89(1057):617–20.PubMedCrossRef
35.
Zurück zum Zitat Pecori Giraldi F, Saccani A, Cavagnini F. Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol. 2011;164(4):505–12.PubMedCrossRef Pecori Giraldi F, Saccani A, Cavagnini F. Assessment of ACTH assay variability: a multicenter study. Eur J Endocrinol. 2011;164(4):505–12.PubMedCrossRef
36.
Zurück zum Zitat Van Rijn JL, Van Landeghem BA, Haima P, Goldschmidt HM. Evaluation of ACTH immunoradiometric assays. Clin Biochem. 1996;29(1):93–5.PubMedCrossRef Van Rijn JL, Van Landeghem BA, Haima P, Goldschmidt HM. Evaluation of ACTH immunoradiometric assays. Clin Biochem. 1996;29(1):93–5.PubMedCrossRef
37.
Zurück zum Zitat Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.PubMedCrossRef Bornstein SR, Allolio B, Arlt W, Barthel A, Don-Wauchope A, Hammer GD, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2016;101(2):364–89.PubMedCrossRef
38.
Zurück zum Zitat Abraham SB, Abel BS, Sinaii N, Saverino E, Wade M, Nieman LK. Primary vs secondary adrenal insufficiency: ACTHstimulated aldosterone diagnostic cut-off values by tandem mass spectrometry. Clin Endocrinol. 2015;83(3):308–14.CrossRef Abraham SB, Abel BS, Sinaii N, Saverino E, Wade M, Nieman LK. Primary vs secondary adrenal insufficiency: ACTHstimulated aldosterone diagnostic cut-off values by tandem mass spectrometry. Clin Endocrinol. 2015;83(3):308–14.CrossRef
39.
Zurück zum Zitat Shi J, Dhaliwal P, Zi Zheng Y, Wong T, Straseski JA, Cervinski MA, et al. An intact ACTH LC-MS/MS assay as an arbiter of clinically discordant immunoassay results. Clin Chem. 2019;65(11):1397–404.PubMedCrossRef Shi J, Dhaliwal P, Zi Zheng Y, Wong T, Straseski JA, Cervinski MA, et al. An intact ACTH LC-MS/MS assay as an arbiter of clinically discordant immunoassay results. Clin Chem. 2019;65(11):1397–404.PubMedCrossRef
40.
Zurück zum Zitat Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;26(7 Suppl):74–82.PubMed Nieman LK. Dynamic evaluation of adrenal hypofunction. J Endocrinol Invest. 2003;26(7 Suppl):74–82.PubMed
41.
Zurück zum Zitat A V. In: GR MV, editor. Androgen secretion by adrenals and gonads. Boston: John Wright–PS; 1983. A V. In: GR MV, editor. Androgen secretion by adrenals and gonads. Boston: John Wright–PS; 1983.
42.
Zurück zum Zitat Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59(3):551–5.PubMedCrossRef Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59(3):551–5.PubMedCrossRef
43.
Zurück zum Zitat Nasrallah MP, Arafah BM. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab. 2003;88(11):5293–8.PubMedCrossRef Nasrallah MP, Arafah BM. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab. 2003;88(11):5293–8.PubMedCrossRef
44.
Zurück zum Zitat Sayyed Kassem L, El Sibai K, Chaiban J, Abdelmannan D, Arafah BM. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency. J Clin Endocrinol Metab. 2012;97(10):3655–62.PubMedPubMedCentralCrossRef Sayyed Kassem L, El Sibai K, Chaiban J, Abdelmannan D, Arafah BM. Measurements of serum DHEA and DHEA sulphate levels improve the accuracy of the low-dose cosyntropin test in the diagnosis of central adrenal insufficiency. J Clin Endocrinol Metab. 2012;97(10):3655–62.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Laureti S, Arvat E, Candeloro P, Di Vito L, Ghigo E, Santeusanio F, et al. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol. 2000;53(1):107–15.CrossRef Laureti S, Arvat E, Candeloro P, Di Vito L, Ghigo E, Santeusanio F, et al. Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's disease. Clin Endocrinol. 2000;53(1):107–15.CrossRef
46.
Zurück zum Zitat Laureti S, Candeloro P, Aglietti MC, Giordano R, Arvat E, Ghigo E, et al. Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity. Clin Endocrinol. 2002;57(5):677–83.CrossRef Laureti S, Candeloro P, Aglietti MC, Giordano R, Arvat E, Ghigo E, et al. Dehydroepiandrosterone, 17alpha-hydroxyprogesterone and aldosterone responses to the low-dose (1 micro g) ACTH test in subjects with preclinical adrenal autoimmunity. Clin Endocrinol. 2002;57(5):677–83.CrossRef
47.
Zurück zum Zitat Topor LS, Asai M, Dunn J, Majzoub JA. Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3 beta-HSD2. J Clin Endocrinol Metab. 2011;96(1):E31–9.PubMedCrossRef Topor LS, Asai M, Dunn J, Majzoub JA. Cortisol stimulates secretion of dehydroepiandrosterone in human adrenocortical cells through inhibition of 3 beta-HSD2. J Clin Endocrinol Metab. 2011;96(1):E31–9.PubMedCrossRef
48.
Zurück zum Zitat Fischli S, Jenni S, Allemann S, Zwahlen M, Diem P, Christ ER, et al. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2008;93(2):539–42.PubMedCrossRef Fischli S, Jenni S, Allemann S, Zwahlen M, Diem P, Christ ER, et al. Dehydroepiandrosterone sulfate in the assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2008;93(2):539–42.PubMedCrossRef
49.
Zurück zum Zitat Charoensri S, Chailurkit L, Muntham D, Bunnag P. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. 2017;7:42–6.PubMedPubMedCentral Charoensri S, Chailurkit L, Muntham D, Bunnag P. Serum dehydroepiandrosterone sulfate in assessing the integrity of the hypothalamic-pituitary-adrenal axis. J Clin Transl Endocrinol. 2017;7:42–6.PubMedPubMedCentral
50.
Zurück zum Zitat Greenwood FC, Landon J, Stamp TC. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. in control subjects. J Clin Invest. 1966;45(4):429–36.PubMedPubMedCentralCrossRef Greenwood FC, Landon J, Stamp TC. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. in control subjects. J Clin Invest. 1966;45(4):429–36.PubMedPubMedCentralCrossRef
51.
Zurück zum Zitat Landon J, Greenwood FC, Stamp TC, Wynn V. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest. 1966;45(4):437–49.PubMedPubMedCentralCrossRef Landon J, Greenwood FC, Stamp TC, Wynn V. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. J Clin Invest. 1966;45(4):437–49.PubMedPubMedCentralCrossRef
52.
Zurück zum Zitat Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol. 1994;41(1):123–8.CrossRef Jones SL, Trainer PJ, Perry L, Wass JA, Bessser GM, Grossman A. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year. Clin Endocrinol. 1994;41(1):123–8.CrossRef
53.
Zurück zum Zitat Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996;44(2):141–6.CrossRef Hurel SJ, Thompson CJ, Watson MJ, Harris MM, Baylis PH, Kendall-Taylor P. The short Synacthen and insulin stress tests in the assessment of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996;44(2):141–6.CrossRef
54.
Zurück zum Zitat Ammari F, Issa BG, Millward E, Scanion MF. A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. Clin Endocrinol. 1996;44(4):473–6.CrossRef Ammari F, Issa BG, Millward E, Scanion MF. A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function. Clin Endocrinol. 1996;44(4):473–6.CrossRef
55.
Zurück zum Zitat Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res. 1997;29(3):106–10.PubMedCrossRef Vestergaard P, Hoeck HC, Jakobsen PE, Laurberg P. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults. Horm Metab Res. 1997;29(3):106–10.PubMedCrossRef
56.
Zurück zum Zitat Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83(7):2350–4.PubMed Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab. 1998;83(7):2350–4.PubMed
57.
Zurück zum Zitat Ambrosi B, Barbetta L, Re T, Passini E, Faglia G. The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function. Eur J Endocrinol. 1998;139(6):575–9.PubMedCrossRef Ambrosi B, Barbetta L, Re T, Passini E, Faglia G. The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function. Eur J Endocrinol. 1998;139(6):575–9.PubMedCrossRef
58.
Zurück zum Zitat Dullaart RP, Riemens SC, Scheek LM, Van Tol A. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Investig. 1999;29(8):663–71.CrossRef Dullaart RP, Riemens SC, Scheek LM, Van Tol A. Insulin decreases plasma cholesteryl ester transfer but not cholesterol esterification in healthy subjects as well as in normotriglyceridaemic patients with type 2 diabetes. Eur J Clin Investig. 1999;29(8):663–71.CrossRef
59.
Zurück zum Zitat Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999;84(3):838–43.PubMed Abdu TA, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endocrinol Metab. 1999;84(3):838–43.PubMed
60.
Zurück zum Zitat Gonzalbez J, Villabona C, Ramon J, Navarro MA, Gimenez O, Ricart W, et al. Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol. 2000;53(2):199–204.CrossRef Gonzalbez J, Villabona C, Ramon J, Navarro MA, Gimenez O, Ricart W, et al. Establishment of reference values for standard dose short synacthen test (250 microgram), low dose short synacthen test (1 microgram) and insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in normal subjects. Clin Endocrinol. 2000;53(2):199–204.CrossRef
61.
Zurück zum Zitat Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, et al. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery. Clin Endocrinol. 2000a;53(3):309–12.CrossRef Courtney CH, McAllister AS, McCance DR, Hadden DR, Leslie H, Sheridan B, et al. The insulin hypoglycaemia and overnight metyrapone tests in the assessment of the hypothalamic-pituitary-adrenal axis following pituitary surgery. Clin Endocrinol. 2000a;53(3):309–12.CrossRef
62.
Zurück zum Zitat Lange M, Svendsen OL, Skakkebaek NE, Müller J, Juul A, Schmiegelow M, et al. An audit of the insulin-tolerance test in 255 patients with pituitary disease. Eur J Endocrinol. 2002;147(1):41–7.PubMedCrossRef Lange M, Svendsen OL, Skakkebaek NE, Müller J, Juul A, Schmiegelow M, et al. An audit of the insulin-tolerance test in 255 patients with pituitary disease. Eur J Endocrinol. 2002;147(1):41–7.PubMedCrossRef
63.
Zurück zum Zitat Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis. Clin Endocrinol. 2008;69(4):603–7.CrossRef Finucane FM, Liew A, Thornton E, Rogers B, Tormey W, Agha A. Clinical insights into the safety and utility of the insulin tolerance test (ITT) in the assessment of the hypothalamo-pituitary-adrenal axis. Clin Endocrinol. 2008;69(4):603–7.CrossRef
64.
Zurück zum Zitat Giordano R, Picu A, Bonelli L, Balbo M, Berardelli R, Marinazzo E, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol. 2008;68(6):935–41.CrossRef Giordano R, Picu A, Bonelli L, Balbo M, Berardelli R, Marinazzo E, et al. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Clin Endocrinol. 2008;68(6):935–41.CrossRef
65.
Zurück zum Zitat Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency: unstimulated early morning cortisol in saliva and serum in comparison with the insulin tolerance test. Horm Metab Res. 2009;41(11):834–9.PubMedCrossRef Deutschbein T, Unger N, Mann K, Petersenn S. Diagnosis of secondary adrenal insufficiency: unstimulated early morning cortisol in saliva and serum in comparison with the insulin tolerance test. Horm Metab Res. 2009;41(11):834–9.PubMedCrossRef
66.
Zurück zum Zitat Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol. 2010;162(3):477–82.PubMedCrossRef Berg C, Meinel T, Lahner H, Yuece A, Mann K, Petersenn S. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery. Eur J Endocrinol. 2010;162(3):477–82.PubMedCrossRef
67.
Zurück zum Zitat Ferrante E, Morelli V, Giavoli C, Mantovani G, Verrua E, Sala E, et al. Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? Hormones. 2012;11(4):428–35.PubMedCrossRef Ferrante E, Morelli V, Giavoli C, Mantovani G, Verrua E, Sala E, et al. Is the 250 μg ACTH test a useful tool for the diagnosis of central hypoadrenalism in adult patients with pituitary disorders? Hormones. 2012;11(4):428–35.PubMedCrossRef
68.
Zurück zum Zitat Cho HY, Kim JH, Kim SW, Shin CS, Park KS, Kim SW, et al. Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250 μg) and the low-dose short Synacthen test (1 μg) in assessing central adrenal insufficiency. Clin Endocrinol. 2014;81(1):77–84.CrossRef Cho HY, Kim JH, Kim SW, Shin CS, Park KS, Kim SW, et al. Different cut-off values of the insulin tolerance test, the high-dose short Synacthen test (250 μg) and the low-dose short Synacthen test (1 μg) in assessing central adrenal insufficiency. Clin Endocrinol. 2014;81(1):77–84.CrossRef
69.
Zurück zum Zitat Simsek Y, Karaca Z, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F. A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders. Clin Endocrinol. 2015;82(1):45–52.CrossRef Simsek Y, Karaca Z, Tanriverdi F, Unluhizarci K, Selcuklu A, Kelestimur F. A comparison of low-dose ACTH, glucagon stimulation and insulin tolerance test in patients with pituitary disorders. Clin Endocrinol. 2015;82(1):45–52.CrossRef
70.
Zurück zum Zitat Simunkova K, Duskova M, Kosak M, Krsek M, Hana V, Hill M, et al. Response of cortisol metabolites in the insulin tolerance test and Synacthen tests. Physiol Res. 2015;64(Suppl 2):S237–46.PubMedCrossRef Simunkova K, Duskova M, Kosak M, Krsek M, Hana V, Hill M, et al. Response of cortisol metabolites in the insulin tolerance test and Synacthen tests. Physiol Res. 2015;64(Suppl 2):S237–46.PubMedCrossRef
71.
Zurück zum Zitat Kacheva S, Kolk K, Morgenthaler NG, Brabant G, Karges W. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress. Clin Endocrinol. 2015;82(4):570–6.CrossRef Kacheva S, Kolk K, Morgenthaler NG, Brabant G, Karges W. Gender-specific co-activation of arginine vasopressin and the hypothalamic-pituitary-adrenal axis during stress. Clin Endocrinol. 2015;82(4):570–6.CrossRef
72.
Zurück zum Zitat Cerina V, Kruljac I, Radosevic JM, Kirigin LS, Stipic D, Pecina HI, et al. Diagnostic accuracy of perioperative measurement of basal anterior pituitary and target gland hormones in predicting adrenal insufficiency after pituitary surgery. Medicine. 2016;95(9):e2898.PubMedPubMedCentralCrossRef Cerina V, Kruljac I, Radosevic JM, Kirigin LS, Stipic D, Pecina HI, et al. Diagnostic accuracy of perioperative measurement of basal anterior pituitary and target gland hormones in predicting adrenal insufficiency after pituitary surgery. Medicine. 2016;95(9):e2898.PubMedPubMedCentralCrossRef
73.
Zurück zum Zitat Kosak M, Duskova M, Starka L, Jandikova H, Pospisilova H, Sramkova M, et al. Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance test. Physiol Res. 2017;66(Suppl 3):S387–s95.PubMedCrossRef Kosak M, Duskova M, Starka L, Jandikova H, Pospisilova H, Sramkova M, et al. Can the gold standard be beaten? How reliable are various modifications of the Synacthen test compared to the insulin tolerance test. Physiol Res. 2017;66(Suppl 3):S387–s95.PubMedCrossRef
74.
Zurück zum Zitat Cadegiani FA, Kater CE. Hypothalamic-pituitary-adrenal (HPA) Axis functioning in overtraining syndrome: findings from endocrine and metabolic responses on overtraining syndrome (EROS)-EROS-HPA Axis. Sports Med Open. 2017;3(1):45.PubMedPubMedCentralCrossRef Cadegiani FA, Kater CE. Hypothalamic-pituitary-adrenal (HPA) Axis functioning in overtraining syndrome: findings from endocrine and metabolic responses on overtraining syndrome (EROS)-EROS-HPA Axis. Sports Med Open. 2017;3(1):45.PubMedPubMedCentralCrossRef
75.
Zurück zum Zitat Taieb A, Asma BA, Yosra H, Amel M, Maha K, Molka C, et al. Assessing the adrenal axis by the glucagon stimulation test in children with idiopathic growth hormone deficiency. Pediatr Endocrinol Diabetes Metab. 2018;24(4):161–6.PubMedCrossRef Taieb A, Asma BA, Yosra H, Amel M, Maha K, Molka C, et al. Assessing the adrenal axis by the glucagon stimulation test in children with idiopathic growth hormone deficiency. Pediatr Endocrinol Diabetes Metab. 2018;24(4):161–6.PubMedCrossRef
76.
Zurück zum Zitat Simsek Y, Karaca Z, Diri H, Tanriverdi F, Unluhizarci K, Kelestemur F. Is biochemical hypoglycemia necessary during an insulin tolerance test? Arc Endocrinol Metab. 2020;64(1):82–8.CrossRef Simsek Y, Karaca Z, Diri H, Tanriverdi F, Unluhizarci K, Kelestemur F. Is biochemical hypoglycemia necessary during an insulin tolerance test? Arc Endocrinol Metab. 2020;64(1):82–8.CrossRef
77.
Zurück zum Zitat Fraser RAF, Smith PH. The value of the glucose tolerance test, the insulin tolerance test and the glucose insulin tolerance test in the diagnosis of endocrinologic disorders of glucose metabolism. J Clin Endocrinol Metab. 1941;1:297–306.CrossRef Fraser RAF, Smith PH. The value of the glucose tolerance test, the insulin tolerance test and the glucose insulin tolerance test in the diagnosis of endocrinologic disorders of glucose metabolism. J Clin Endocrinol Metab. 1941;1:297–306.CrossRef
78.
Zurück zum Zitat Lee P, Greenfield JR, Ho KK. Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery. Clin Endocrinol. 2009;71(1):82–5.CrossRef Lee P, Greenfield JR, Ho KK. Factors determining inadequate hypoglycaemia during insulin tolerance testing (ITT) after pituitary surgery. Clin Endocrinol. 2009;71(1):82–5.CrossRef
79.
Zurück zum Zitat Zhang Y, Sun S, Jia H, Qi Y, Zhang J, Lin L, et al. The optimized calculation method for insulin dosage in an insulin tolerance test (ITT): a randomized parallel control study. Front Endocrinol. 2020;11:202.CrossRef Zhang Y, Sun S, Jia H, Qi Y, Zhang J, Lin L, et al. The optimized calculation method for insulin dosage in an insulin tolerance test (ITT): a randomized parallel control study. Front Endocrinol. 2020;11:202.CrossRef
80.
Zurück zum Zitat Dickstein G. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts? J Endocrinol Investig. 2003;26(7 Suppl):25–30. Dickstein G. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts? J Endocrinol Investig. 2003;26(7 Suppl):25–30.
81.
Zurück zum Zitat Ajala O, Lockett H, Twine G, Flanagan DE. Depth and duration of hypoglycaemia achieved during the insulin tolerance test. Eur J Endocrinol. 2012;167(1):59–65.PubMedCrossRef Ajala O, Lockett H, Twine G, Flanagan DE. Depth and duration of hypoglycaemia achieved during the insulin tolerance test. Eur J Endocrinol. 2012;167(1):59–65.PubMedCrossRef
82.
Zurück zum Zitat Borm K, Slawik M, Beuschlein F, Seiler L, Flohr F, Berg A, et al. Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient's discomfort in a pilot study. Eur J Endocrinol. 2005;153(4):521–6.PubMedCrossRef Borm K, Slawik M, Beuschlein F, Seiler L, Flohr F, Berg A, et al. Low-dose glucose infusion after achieving critical hypoglycemia during insulin tolerance testing: effects on time of hypoglycemia, neuroendocrine stress response and patient's discomfort in a pilot study. Eur J Endocrinol. 2005;153(4):521–6.PubMedCrossRef
83.
Zurück zum Zitat Thorn GW, Forsham PH. A test for adrenal cortical insufficiency; the response to pituitary andrenocorticotropic hormone. J Am Med Assoc. 1948;137(12):1005–9.PubMedCrossRef Thorn GW, Forsham PH. A test for adrenal cortical insufficiency; the response to pituitary andrenocorticotropic hormone. J Am Med Assoc. 1948;137(12):1005–9.PubMedCrossRef
84.
Zurück zum Zitat Kelestimur F, Akgun A, Gunay O. A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects. J Endocrinol Invest. 1995;18(11):823–6.PubMedCrossRef Kelestimur F, Akgun A, Gunay O. A comparison between short synacthen test and depot synacthen test in the evaluation of cortisol reserve of adrenal gland in normal subjects. J Endocrinol Invest. 1995;18(11):823–6.PubMedCrossRef
85.
Zurück zum Zitat Landon J, Wynn V, James VH, Wood JB. Adrenal response to infused corticotropin in subjects receiving glucocorticoids. J Clin Endocrinol Metab. 1965;25:602–11.PubMedCrossRef Landon J, Wynn V, James VH, Wood JB. Adrenal response to infused corticotropin in subjects receiving glucocorticoids. J Clin Endocrinol Metab. 1965;25:602–11.PubMedCrossRef
86.
Zurück zum Zitat Wood JB, Frankland AW, James VH, Landon J. A rapid test of adrenocortical function. Lancet. 1965;1(7379):243–5.PubMedCrossRef Wood JB, Frankland AW, James VH, Landon J. A rapid test of adrenocortical function. Lancet. 1965;1(7379):243–5.PubMedCrossRef
87.
Zurück zum Zitat Kehlet H, Binder C. Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J. 1973;2(5859):147–9.PubMedPubMedCentralCrossRef Kehlet H, Binder C. Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J. 1973;2(5859):147–9.PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Kehlet H, Blichert-Toft M, Lindholm J, Rasmussen P. Short ACTH test in assessing hypothalamic-pituitary-adrenocortical function. Br Med J. 1976;1(6004):249–51.PubMedPubMedCentralCrossRef Kehlet H, Blichert-Toft M, Lindholm J, Rasmussen P. Short ACTH test in assessing hypothalamic-pituitary-adrenocortical function. Br Med J. 1976;1(6004):249–51.PubMedPubMedCentralCrossRef
89.
Zurück zum Zitat Cunningham SK, Moore A, McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med. 1983;143(12):2276–9.PubMedCrossRef Cunningham SK, Moore A, McKenna TJ. Normal cortisol response to corticotropin in patients with secondary adrenal failure. Arch Intern Med. 1983;143(12):2276–9.PubMedCrossRef
90.
Zurück zum Zitat Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991;72(4):773–8.PubMedCrossRef Dickstein G, Shechner C, Nicholson WE, Rosner I, Shen-Orr Z, Adawi F, et al. Adrenocorticotropin stimulation test: effects of basal cortisol level, time of day, and suggested new sensitive low dose test. J Clin Endocrinol Metab. 1991;72(4):773–8.PubMedCrossRef
91.
Zurück zum Zitat Soule S, Van Zyl SC, Parolis G, Attenborough S, Peter D, Kinvig S, et al. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism. Clin Endocrinol. 2000;53(2):221–7.CrossRef Soule S, Van Zyl SC, Parolis G, Attenborough S, Peter D, Kinvig S, et al. The low dose ACTH stimulation test is less sensitive than the overnight metyrapone test for the diagnosis of secondary hypoadrenalism. Clin Endocrinol. 2000;53(2):221–7.CrossRef
92.
Zurück zum Zitat Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2006;91(1):43–7.PubMedCrossRef Agha A, Tomlinson JW, Clark PM, Holder G, Stewart PM. The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 2006;91(1):43–7.PubMedCrossRef
93.
Zurück zum Zitat Dekkers OM, Timmermans JM, Smit JW, Romijn JA, Pereira AM. Comparison of the cortisol responses to testing with two doses of ACTH in patients with suspected adrenal insufficiency. Eur J Endocrinol. 2011;164(1):83–7.PubMedCrossRef Dekkers OM, Timmermans JM, Smit JW, Romijn JA, Pereira AM. Comparison of the cortisol responses to testing with two doses of ACTH in patients with suspected adrenal insufficiency. Eur J Endocrinol. 2011;164(1):83–7.PubMedCrossRef
94.
Zurück zum Zitat Karaca Z, Lale A, Tanriverdi F, Kula M, Unluhizarci K, Kelestimur F. The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary. 2011;14(2):134–40.PubMedCrossRef Karaca Z, Lale A, Tanriverdi F, Kula M, Unluhizarci K, Kelestimur F. The comparison of low and standard dose ACTH and glucagon stimulation tests in the evaluation of hypothalamo-pituitary-adrenal axis in healthy adults. Pituitary. 2011;14(2):134–40.PubMedCrossRef
95.
Zurück zum Zitat Lekkakou L, Tzanela M, Lymberi M, Consoulas C, Tsagarakis S, Koutsilieris M. Effects of gender and age on hypothalamicpituitary-adrenal reactivity after pharmacological challenge with low-dose 1-μg ACTH test: a prospective study in healthy adults. Clin Endocrinol. 2013;79(5):683–8. Lekkakou L, Tzanela M, Lymberi M, Consoulas C, Tsagarakis S, Koutsilieris M. Effects of gender and age on hypothalamicpituitary-adrenal reactivity after pharmacological challenge with low-dose 1-μg ACTH test: a prospective study in healthy adults. Clin Endocrinol. 2013;79(5):683–8.
96.
Zurück zum Zitat Chitale A, Musonda P, McGregor AM, Dhatariya KK. Determining the utility of the 60 min cortisol measurement in the short synacthen test. Clin Endocrinol. 2013;79(1):14–9.CrossRef Chitale A, Musonda P, McGregor AM, Dhatariya KK. Determining the utility of the 60 min cortisol measurement in the short synacthen test. Clin Endocrinol. 2013;79(1):14–9.CrossRef
97.
Zurück zum Zitat Mak IYF, Au Yeung BYT, Ng YW, Choi CH, Iu HYP, Shek CC, et al. Salivary cortisol and cortisone after low-dose Corticotropin stimulation in the diagnosis of adrenal insufficiency. J Endocr Soc. 2017;1(2):96–108.PubMedPubMedCentralCrossRef Mak IYF, Au Yeung BYT, Ng YW, Choi CH, Iu HYP, Shek CC, et al. Salivary cortisol and cortisone after low-dose Corticotropin stimulation in the diagnosis of adrenal insufficiency. J Endocr Soc. 2017;1(2):96–108.PubMedPubMedCentralCrossRef
98.
Zurück zum Zitat Struja T, Briner L, Meier A, Kutz A, Mundwiler E, Huber A, et al. Diagnostic accuracy of basal cortisol level to predict adrenal insufficiency in cosyntropin testing: results from an observational cohort study with 804 patients. Endocr Pract. 2017;23(8):949–61.PubMedCrossRef Struja T, Briner L, Meier A, Kutz A, Mundwiler E, Huber A, et al. Diagnostic accuracy of basal cortisol level to predict adrenal insufficiency in cosyntropin testing: results from an observational cohort study with 804 patients. Endocr Pract. 2017;23(8):949–61.PubMedCrossRef
99.
Zurück zum Zitat Mongioi LM, Condorelli RA. Accuracy of the low-dose ACTH stimulation test for adrenal insufficiency diagnosis: a re-assessment of the cut-off value. J Clin Med. 2019;8(6):806.PubMedCentralCrossRef Mongioi LM, Condorelli RA. Accuracy of the low-dose ACTH stimulation test for adrenal insufficiency diagnosis: a re-assessment of the cut-off value. J Clin Med. 2019;8(6):806.PubMedCentralCrossRef
100.
Zurück zum Zitat Garg A, Mishra SK, Dubey S, Singh VP, Kuchay MS, Mithal A. Low-dose ACTH test for evaluation of hypothalamus-pituitaryadrenal axis preoperatively and 3-month follow-up in nonfunctioning pituitary adenomas. J Endocrinol Invest. 2020; 43(12):1769–1777. Garg A, Mishra SK, Dubey S, Singh VP, Kuchay MS, Mithal A. Low-dose ACTH test for evaluation of hypothalamus-pituitaryadrenal axis preoperatively and 3-month follow-up in nonfunctioning pituitary adenomas. J Endocrinol Invest. 2020; 43(12):1769–1777.
101.
Zurück zum Zitat Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB, et al. The short Synacthen (Corticotropin) test can be used to predict recovery of Hypothalamo-pituitary-adrenal Axis function. J Clin Endocrinol Metab. 2018;103(8):3050–9.PubMedCrossRef Pofi R, Feliciano C, Sbardella E, Argese N, Woods CP, Grossman AB, et al. The short Synacthen (Corticotropin) test can be used to predict recovery of Hypothalamo-pituitary-adrenal Axis function. J Clin Endocrinol Metab. 2018;103(8):3050–9.PubMedCrossRef
102.
Zurück zum Zitat Pofi R, Gunatilake S, Macgregor V, Shine B, Joseph R, Grossman AB, et al. Recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal adenomectomy for non-ACTH-secreting macroadenomas. J Clin Endocrinol Metab. 2019;104(11):5316–24.PubMedCrossRef Pofi R, Gunatilake S, Macgregor V, Shine B, Joseph R, Grossman AB, et al. Recovery of the hypothalamo-pituitary-adrenal axis after transsphenoidal adenomectomy for non-ACTH-secreting macroadenomas. J Clin Endocrinol Metab. 2019;104(11):5316–24.PubMedCrossRef
103.
Zurück zum Zitat Speckart PF, Nicoloff JT, Bethune JE. Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med. 1971;128(5):761–3.PubMedCrossRef Speckart PF, Nicoloff JT, Bethune JE. Screening for adrenocortical insufficiency with cosyntropin (synthetic ACTH). Arch Intern Med. 1971;128(5):761–3.PubMedCrossRef
104.
Zurück zum Zitat May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med. 1985;79(6):679–84.PubMedCrossRef May ME, Carey RM. Rapid adrenocorticotropic hormone test in practice. Retrospective review. Am J Med. 1985;79(6):679–84.PubMedCrossRef
105.
Zurück zum Zitat Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, et al. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Endocr J. 2018;65(9):935–42.PubMedCrossRef Ach T, Yosra H, Jihen M, Abdelkarim Asma B, Maha K, Molka C, et al. Cortisol cut-points for the glucagon stimulation test in the evaluation of hypothalamic pituitary adrenal axis. Endocr J. 2018;65(9):935–42.PubMedCrossRef
106.
Zurück zum Zitat Ben-Shlomo A, Guzman J, Mirocha J. Enhanced cosyntropin stimulation test performance enabled by electronic medical record. Pituitary. 2016;19(5):503–6.PubMedCrossRef Ben-Shlomo A, Guzman J, Mirocha J. Enhanced cosyntropin stimulation test performance enabled by electronic medical record. Pituitary. 2016;19(5):503–6.PubMedCrossRef
107.
Zurück zum Zitat Inder WJ. Long-acting porcine sequence ACTH in the diagnosis of adrenal insufficiency: a cost-effective alternative to the ACTH1-24 test. Eur J Endocrinol. 2020;182(2):C5–c7.PubMedCrossRef Inder WJ. Long-acting porcine sequence ACTH in the diagnosis of adrenal insufficiency: a cost-effective alternative to the ACTH1-24 test. Eur J Endocrinol. 2020;182(2):C5–c7.PubMedCrossRef
108.
Zurück zum Zitat Elder CJ, Vilela R, Johnson TN, Taylor RN, Kemp EH, Keevil BG, et al. Pharmacodynamic studies of nasal tetracosactide with salivary glucocorticoids for a noninvasive Short Synacthen Test. J Clin Endocrinol Metab. 2020;105(8):dgaa323.PubMedCrossRef Elder CJ, Vilela R, Johnson TN, Taylor RN, Kemp EH, Keevil BG, et al. Pharmacodynamic studies of nasal tetracosactide with salivary glucocorticoids for a noninvasive Short Synacthen Test. J Clin Endocrinol Metab. 2020;105(8):dgaa323.PubMedCrossRef
109.
Zurück zum Zitat Oelkers W. Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin test. Eur J Endocrinol. 1996;135(1):27–33.PubMedCrossRef Oelkers W. Dose-response aspects in the clinical assessment of the hypothalamo-pituitary-adrenal axis, and the low-dose adrenocorticotropin test. Eur J Endocrinol. 1996;135(1):27–33.PubMedCrossRef
110.
Zurück zum Zitat Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insülin tolerance test in the assessment of hypothalamo-pituitaryadrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab. 2000;85(10):3713–9.PubMed Dokmetas HS, Colak R, Kelestimur F, Selcuklu A, Unluhizarci K, Bayram F. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insülin tolerance test in the assessment of hypothalamo-pituitaryadrenal axis immediately after pituitary surgery. J Clin Endocrinol Metab. 2000;85(10):3713–9.PubMed
111.
Zurück zum Zitat Mukherjee JJ, de Castro JJ, Kaltsas G, Afshar F, Grossman AB, Wass JA, et al. A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol. 1997;47(1):51–60.CrossRef Mukherjee JJ, de Castro JJ, Kaltsas G, Afshar F, Grossman AB, Wass JA, et al. A comparison of the insulin tolerance/glucagon test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol. 1997;47(1):51–60.CrossRef
112.
Zurück zum Zitat Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab. 1995;80(4):1301–5.PubMed Tordjman K, Jaffe A, Grazas N, Apter C, Stern N. The role of the low dose (1 microgram) adrenocorticotropin test in the evaluation of patients with pituitary diseases. J Clin Endocrinol Metab. 1995;80(4):1301–5.PubMed
113.
Zurück zum Zitat Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996;44(2):151–156. Rasmuson S, Olsson T, Hagg E. A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1996;44(2):151–156.
114.
Zurück zum Zitat Dennedy MC. Salivary cortisone and cortisol following synacthen, a future replacement for serum cortisol? Commentary to: use of salivary cortisol and cortisone in the high and low dose synacthen test. Clin Endocrinol. 2018;88(6):770–1.CrossRef Dennedy MC. Salivary cortisone and cortisol following synacthen, a future replacement for serum cortisol? Commentary to: use of salivary cortisol and cortisone in the high and low dose synacthen test. Clin Endocrinol. 2018;88(6):770–1.CrossRef
115.
Zurück zum Zitat Murphy H, Livesey J, Espiner EA, Donald RA. The low döşe ACTH test–a further word of caution. J Clin Endocrinol Metab. 1998;83(2):712–3.PubMed Murphy H, Livesey J, Espiner EA, Donald RA. The low döşe ACTH test–a further word of caution. J Clin Endocrinol Metab. 1998;83(2):712–3.PubMed
116.
Zurück zum Zitat Wade M, Baid S, Calis K, Raff H, Sinaii N, Nieman L. Technical details influence the diagnostic accuracy of the 1 microg ACTH stimulation test. Eur J Endocrinol. 2010;162(1):109–13.PubMedCrossRef Wade M, Baid S, Calis K, Raff H, Sinaii N, Nieman L. Technical details influence the diagnostic accuracy of the 1 microg ACTH stimulation test. Eur J Endocrinol. 2010;162(1):109–13.PubMedCrossRef
117.
Zurück zum Zitat Saiegh L, Abu-Ahmad A, Sheikh-Ahmad M, Reut M, Chen-Konak L, Jiries N, et al. Performance of low-dose cosyntropin stimulation test handled via plastic tube. Endocrine. 2017;57(1):46–50.PubMedCrossRef Saiegh L, Abu-Ahmad A, Sheikh-Ahmad M, Reut M, Chen-Konak L, Jiries N, et al. Performance of low-dose cosyntropin stimulation test handled via plastic tube. Endocrine. 2017;57(1):46–50.PubMedCrossRef
118.
Zurück zum Zitat Spathis GS, BloomSR JWJ, Millar JG, Kurtz A, Pyasena MR, et al. Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH. Clin Endocrinol. 1974;3(2):175–86.CrossRef Spathis GS, BloomSR JWJ, Millar JG, Kurtz A, Pyasena MR, et al. Subcutaneous glucagon as a test of the ability of the pituitary to secrete GH and ACTH. Clin Endocrinol. 1974;3(2):175–86.CrossRef
119.
Zurück zum Zitat Waldhäusl W, Haydl H, Nowotny P. ACTH and cortisol responses to glucagon stimulation. J Clin Endocrinol Metab. 1976;43(3):675–8.PubMedCrossRef Waldhäusl W, Haydl H, Nowotny P. ACTH and cortisol responses to glucagon stimulation. J Clin Endocrinol Metab. 1976;43(3):675–8.PubMedCrossRef
120.
Zurück zum Zitat Rao RH, Spathis GS. Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metab Clin Exp. 1987;36(7):658–63.PubMedCrossRef Rao RH, Spathis GS. Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metab Clin Exp. 1987;36(7):658–63.PubMedCrossRef
121.
Zurück zum Zitat Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol. 1989;31(5):527–33.CrossRef Littley MD, Gibson S, White A, Shalet SM. Comparison of the ACTH and cortisol responses to provocative testing with glucagon and insulin hypoglycaemia in normal subjects. Clin Endocrinol. 1989;31(5):527–33.CrossRef
122.
Zurück zum Zitat Leong KS, Walker AB, Martin I, Wile D, Wilding J, MacFarlane IA. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clin Endocrinol. 2001;54(4):463–8.CrossRef Leong KS, Walker AB, Martin I, Wile D, Wilding J, MacFarlane IA. An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clin Endocrinol. 2001;54(4):463–8.CrossRef
123.
Zurück zum Zitat Agha A, Rogers B, Sherlock M, O'Kelly P, TormeyW PJ, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89(10):4929–36.PubMedCrossRef Agha A, Rogers B, Sherlock M, O'Kelly P, TormeyW PJ, et al. Anterior pituitary dysfunction in survivors of traumatic brain injury. J Clin Endocrinol Metab. 2004;89(10):4929–36.PubMedCrossRef
124.
Zurück zum Zitat Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, et al. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12months after the event. Clin Endocrinol. 2007;67(6):931–7.CrossRef Tanriverdi F, Dagli AT, Karaca Z, Unluhizarci K, Selcuklu A, Casanueva FF, et al. High risk of pituitary dysfunction due to aneurysmal subarachnoid haemorrhage: a prospective investigation of anterior pituitary function in the acute phase and 12months after the event. Clin Endocrinol. 2007;67(6):931–7.CrossRef
125.
Zurück zum Zitat Cegla J, Jones B, Seyani L, Papadoulou D, Wynne K, Martin NM, et al. Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism. Clin Endocrinol. 2013;78(5):738–42.CrossRef Cegla J, Jones B, Seyani L, Papadoulou D, Wynne K, Martin NM, et al. Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalism. Clin Endocrinol. 2013;78(5):738–42.CrossRef
126.
Zurück zum Zitat Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, et al. Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary. 2013;16(2):220–30.PubMedCrossRef Yuen KC, Biller BM, Katznelson L, Rhoads SA, Gurel MH, Chu O, et al. Clinical characteristics, timing of peak responses and safety aspects of two dosing regimens of the glucagon stimulation test in evaluating growth hormone and cortisol secretion in adults. Pituitary. 2013;16(2):220–30.PubMedCrossRef
127.
Zurück zum Zitat Lewandowski KC, Lewinski A, Skowronska-Jozwiak E, Stasiak M, Horzelski W, Brabant G. Copeptin under glucagon stimulation. Endocrine. 2016;52(2):344–51.PubMedCrossRef Lewandowski KC, Lewinski A, Skowronska-Jozwiak E, Stasiak M, Horzelski W, Brabant G. Copeptin under glucagon stimulation. Endocrine. 2016;52(2):344–51.PubMedCrossRef
128.
Zurück zum Zitat Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. 2016;19(3):332–41.PubMedCrossRef Hamrahian AH, Yuen KC, Gordon MB, Pulaski-Liebert KJ, Bena J, Biller BM. Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic pituitary-adrenal axes in adults: results from a prospective randomized multicenter study. Pituitary. 2016;19(3):332–41.PubMedCrossRef
129.
Zurück zum Zitat Tavares ABW, Seixas-da-Silva IA, Silvestre DHS, Pinheiro MFC, Vaisman M, Conceicao FL. Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test. Endocrine. 2017;56(2):317–24.PubMedCrossRef Tavares ABW, Seixas-da-Silva IA, Silvestre DHS, Pinheiro MFC, Vaisman M, Conceicao FL. Growth hormone and cortisol secretion in the elderly evaluated using the glucagon stimulation test. Endocrine. 2017;56(2):317–24.PubMedCrossRef
130.
Zurück zum Zitat Salata RA, Jarrett DB, Verbalis JG, Robinson AG. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest. 1988;81(3):766–74.PubMedPubMedCentralCrossRef Salata RA, Jarrett DB, Verbalis JG, Robinson AG. Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J Clin Invest. 1988;81(3):766–74.PubMedPubMedCentralCrossRef
131.
Zurück zum Zitat Arvat E, Maccagno B, Ramunni J, Giordano R, DiVito L, Broglio F, et al. Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects. Pituitary. 2000a;3(3):169–73.PubMedCrossRef Arvat E, Maccagno B, Ramunni J, Giordano R, DiVito L, Broglio F, et al. Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects. Pituitary. 2000a;3(3):169–73.PubMedCrossRef
132.
Zurück zum Zitat Arvat E, Maccagno B, Ramunni J, Maccario M, Giordano R, Broglio F, et al. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur J Endocrinol. 2000b;143(1):99–104.PubMedCrossRef Arvat E, Maccagno B, Ramunni J, Maccario M, Giordano R, Broglio F, et al. Interaction between glucagon and human corticotropin-releasing hormone or vasopressin on ACTH and cortisol secretion in humans. Eur J Endocrinol. 2000b;143(1):99–104.PubMedCrossRef
133.
Zurück zum Zitat Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, et al. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans. Clin Endocrinol. 2004;60(6):699–704.CrossRef Broglio F, Prodam F, Gottero C, Destefanis S, Me E, Riganti F, et al. Ghrelin does not mediate the somatotroph and corticotroph responses to the stimulatory effect of glucagon or insulin-induced hypoglycaemia in humans. Clin Endocrinol. 2004;60(6):699–704.CrossRef
134.
Zurück zum Zitat Unluhizarci K, Kokoglu EO, Hacioglu A, Karaca Z, Kelestimur F. Comparison of a combination test (1 μg ACTH test plus glucagon test) versus 1 μg ACTH test and glucagon test in the evaluation of the hypothalamic-pituitary-adrenal axis in patients with pituitary disorders. Arc Endocrinol Metab. 2020. Unluhizarci K, Kokoglu EO, Hacioglu A, Karaca Z, Kelestimur F. Comparison of a combination test (1 μg ACTH test plus glucagon test) versus 1 μg ACTH test and glucagon test in the evaluation of the hypothalamic-pituitary-adrenal axis in patients with pituitary disorders. Arc Endocrinol Metab. 2020.
135.
Zurück zum Zitat Liddle GW, Estep HL, Kendall JW Jr, Williams WC Jr, Townes AW. Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab. 1959;19:875–94.PubMedCrossRef Liddle GW, Estep HL, Kendall JW Jr, Williams WC Jr, Townes AW. Clinical application of a new test of pituitary reserve. J Clin Endocrinol Metab. 1959;19:875–94.PubMedCrossRef
136.
Zurück zum Zitat Buus O, Binder C, Petersen F. Metopirone dosage in pituitary function test. Lancet. 1962;1(7238):1040–1.PubMedCrossRef Buus O, Binder C, Petersen F. Metopirone dosage in pituitary function test. Lancet. 1962;1(7238):1040–1.PubMedCrossRef
137.
Zurück zum Zitat Metcalf MG, Beaven DW. The metopirone test of pituitary corticotrophin release. Evaluation of 101 tests. Am J Med. 1968;45(2):176–86.PubMed Metcalf MG, Beaven DW. The metopirone test of pituitary corticotrophin release. Evaluation of 101 tests. Am J Med. 1968;45(2):176–86.PubMed
138.
Zurück zum Zitat Strott CA, West CD, Nakagawa K, Kondo T, Tyler FH. Plasma 11-deoxycorticosteroid and ACTH response to metyrapone (plasma metyrapone test). J Clin Endocrinol Metab. 1969;29(1):6–11.PubMedCrossRef Strott CA, West CD, Nakagawa K, Kondo T, Tyler FH. Plasma 11-deoxycorticosteroid and ACTH response to metyrapone (plasma metyrapone test). J Clin Endocrinol Metab. 1969;29(1):6–11.PubMedCrossRef
139.
Zurück zum Zitat Jubiz W, Meikle AW, West CD, Tyler FH. Single-dose metyrapone test. Arch Intern Med. 1970;125(3):472–4.PubMedCrossRef Jubiz W, Meikle AW, West CD, Tyler FH. Single-dose metyrapone test. Arch Intern Med. 1970;125(3):472–4.PubMedCrossRef
140.
Zurück zum Zitat Meikle AW, West SC, Weed JA, Tyler FH. Single dose metyrapone test: 11 beta-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay. J Clin Endocrinol Metab. 1975;40(2):290–5.PubMedCrossRef Meikle AW, West SC, Weed JA, Tyler FH. Single dose metyrapone test: 11 beta-hydroxylase inhibition by metyrapone and reduced metyrapone assayed by radioimmunoassay. J Clin Endocrinol Metab. 1975;40(2):290–5.PubMedCrossRef
141.
Zurück zum Zitat Spiger M, Jubiz W, Meikle AW, West CD, Tylor FH. Single-dose metyrapone test: review of a four-year experience. Arch Intern Med. 1975;135(5):698–700. Spiger M, Jubiz W, Meikle AW, West CD, Tylor FH. Single-dose metyrapone test: review of a four-year experience. Arch Intern Med. 1975;135(5):698–700.
142.
Zurück zum Zitat Staub JJ, Noelpp B, Girard J, Baumann JB, Graf S, Ratcliffe JG. The short metyrapone test: comparison of the plasma ACTH response to metyrapone and insulin-induced hypoglycaemia. Clin Endocrinol. 1979;10(6):595–601.CrossRef Staub JJ, Noelpp B, Girard J, Baumann JB, Graf S, Ratcliffe JG. The short metyrapone test: comparison of the plasma ACTH response to metyrapone and insulin-induced hypoglycaemia. Clin Endocrinol. 1979;10(6):595–601.CrossRef
143.
Zurück zum Zitat Dolman LI, Nolan G, Jubiz W. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency. JAMA. 1979;241(12):1251–3.PubMedCrossRef Dolman LI, Nolan G, Jubiz W. Metyrapone test with adrenocorticotrophic levels. Separating primary from secondary adrenal insufficiency. JAMA. 1979;241(12):1251–3.PubMedCrossRef
144.
Zurück zum Zitat Feek CM, Bevan JS, Ratcliffe JG, Gray CE, Blundell G. The short metyrapone test: comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced hypoglycaemia in patients with pituitary disease. Clin Endocrinol. 1981;15(1):75–80. Feek CM, Bevan JS, Ratcliffe JG, Gray CE, Blundell G. The short metyrapone test: comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced hypoglycaemia in patients with pituitary disease. Clin Endocrinol. 1981;15(1):75–80.
145.
Zurück zum Zitat Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B. Combined stimulation of adrenocorticotropin and compound-S by single dosemetyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab. 2002;87(12):5470–5.PubMedCrossRef Berneis K, Staub JJ, Gessler A, Meier C, Girard J, Muller B. Combined stimulation of adrenocorticotropin and compound-S by single dosemetyrapone test as an outpatient procedure to assess hypothalamic-pituitary-adrenal function. J Clin Endocrinol Metab. 2002;87(12):5470–5.PubMedCrossRef
146.
Zurück zum Zitat English K, Inder WJ. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery. Clin Endocrinol. 2017;87(1):35–43.CrossRef English K, Inder WJ. Prospective evaluation of a week one overnight metyrapone test with subsequent dynamic assessments of hypothalamic-pituitary-adrenal axis function after pituitary surgery. Clin Endocrinol. 2017;87(1):35–43.CrossRef
147.
Zurück zum Zitat Hartzband PI, Van Herle AJ, Sorger L, Cope D. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone. J Endocrinol Invest. 1988;11(11):769–76.PubMedCrossRef Hartzband PI, Van Herle AJ, Sorger L, Cope D. Assessment of hypothalamic-pituitary-adrenal (HPA) axis dysfunction: comparison of ACTH stimulation, insulin-hypoglycemia and metyrapone. J Endocrinol Invest. 1988;11(11):769–76.PubMedCrossRef
148.
Zurück zum Zitat Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1994;40(5):603–9.CrossRef Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol. 1994;40(5):603–9.CrossRef
149.
Zurück zum Zitat Steiner H, Bahr V, Exner P, Oelkers PW. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test. Exp Clin Endocrinol. 1994;102(1):33–8.PubMedCrossRef Steiner H, Bahr V, Exner P, Oelkers PW. Pituitary function tests: comparison of ACTH and 11-deoxy-cortisol responses in the metyrapone test and with the insulin hypoglycemia test. Exp Clin Endocrinol. 1994;102(1):33–8.PubMedCrossRef
150.
Zurück zum Zitat Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992;326(4):226–30.PubMedCrossRef Schlaghecke R, Kornely E, Santen RT, Ridderskamp P. The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone. N Engl J Med. 1992;326(4):226–30.PubMedCrossRef
151.
Zurück zum Zitat Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, et al. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol. 2005;152(5):735–41.PubMedCrossRef Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, et al. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Eur J Endocrinol. 2005;152(5):735–41.PubMedCrossRef
152.
Zurück zum Zitat Kokshoorn NE, Romijn JA, Roelfsema F, Rambach AH, Smit JW, Biermasz NR, et al. The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas. Pituitary. 2012;15(3):436–44.PubMedCrossRef Kokshoorn NE, Romijn JA, Roelfsema F, Rambach AH, Smit JW, Biermasz NR, et al. The use of an early postoperative CRH test to assess adrenal function after transsphenoidal surgery for pituitary adenomas. Pituitary. 2012;15(3):436–44.PubMedCrossRef
153.
Zurück zum Zitat de Vries F, Lobatto DJ. Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test. Endocrine. 2020;67(1):161–71.PubMedCrossRef de Vries F, Lobatto DJ. Early postoperative HPA-axis testing after pituitary tumor surgery: reliability and safety of basal cortisol and CRH test. Endocrine. 2020;67(1):161–71.PubMedCrossRef
154.
Zurück zum Zitat Kano T, Sugihara H, Sudo M, Nagao M, Harada T, Ishizaki A, et al. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study. Peptides. 2010;31(4):657–61.PubMedCrossRef Kano T, Sugihara H, Sudo M, Nagao M, Harada T, Ishizaki A, et al. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study. Peptides. 2010;31(4):657–61.PubMedCrossRef
155.
Zurück zum Zitat Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–60.PubMedCrossRef Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656–60.PubMedCrossRef
156.
Zurück zum Zitat Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, et al. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res. 2003;35(8):455–9.PubMedCrossRef Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, et al. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res. 2003;35(8):455–9.PubMedCrossRef
157.
Zurück zum Zitat Hayakawa T, Kitamura T, Tamada D, Mukai K, Hayashi R, Takahara M, et al. Evaluation of hypothalamic-pituitary-adrenal axis by the GHRP2 test: comparison with the insulin tolerance test. J Endocr Soc. 2018;2(8):860–9.PubMedPubMedCentralCrossRef Hayakawa T, Kitamura T, Tamada D, Mukai K, Hayashi R, Takahara M, et al. Evaluation of hypothalamic-pituitary-adrenal axis by the GHRP2 test: comparison with the insulin tolerance test. J Endocr Soc. 2018;2(8):860–9.PubMedPubMedCentralCrossRef
158.
Zurück zum Zitat Arimura H, Hashiguchi H, Yamamoto K, Shinnakasu A, Arimura A, Kikuchi A, et al. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. Endocr J. 2016;63(6):533–44.PubMedCrossRef Arimura H, Hashiguchi H, Yamamoto K, Shinnakasu A, Arimura A, Kikuchi A, et al. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure. Endocr J. 2016;63(6):533–44.PubMedCrossRef
159.
Zurück zum Zitat Gasco V, Berton A, Caprino MP, Karamouzis I, Maccario M, Ghigo E, et al. Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease. Endocrine. 2015;50(2):474–82.PubMedCrossRef Gasco V, Berton A, Caprino MP, Karamouzis I, Maccario M, Ghigo E, et al. Acylated ghrelin as provocative test for the diagnosis of ACTH deficiency in patients with hypothalamus-pituitary disease. Endocrine. 2015;50(2):474–82.PubMedCrossRef
160.
161.
Zurück zum Zitat Fridman-Bengtsson O, Hoybye C, Porthen L, Stjarne P, Hulting AL, Sunnergren O. Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery. Acta Neurochir. 2019;161(8):1715–21.PubMedCrossRef Fridman-Bengtsson O, Hoybye C, Porthen L, Stjarne P, Hulting AL, Sunnergren O. Evaluation of different hydrocortisone treatment strategies in transsphenoidal pituitary surgery. Acta Neurochir. 2019;161(8):1715–21.PubMedCrossRef
162.
Zurück zum Zitat Cozzi R, Lasio G, Cardia A, Felisati G, Montini M, Attanasio R. Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas. J Endocrinol Invest. 2009;32(5):460–4.PubMedCrossRef Cozzi R, Lasio G, Cardia A, Felisati G, Montini M, Attanasio R. Perioperative cortisol can predict hypothalamus-pituitary-adrenal status in clinically non-functioning pituitary adenomas. J Endocrinol Invest. 2009;32(5):460–4.PubMedCrossRef
163.
Zurück zum Zitat Marko NF, Hamrahian AH, Weil RJ. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors. Pituitary. 2010;13(3):249–55.PubMedCrossRef Marko NF, Hamrahian AH, Weil RJ. Immediate postoperative cortisol levels accurately predict postoperative hypothalamic-pituitary-adrenal axis function after transsphenoidal surgery for pituitary tumors. Pituitary. 2010;13(3):249–55.PubMedCrossRef
164.
Zurück zum Zitat Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma. Endocrine. 2018;62(1):83–9.PubMedPubMedCentralCrossRef Borg H, Siesjö P, Kahlon B, Fjalldal S, Erfurth EM. Perioperative serum cortisol levels in ACTH sufficient and ACTH deficient patients during transsphenoidal surgery of pituitary adenoma. Endocrine. 2018;62(1):83–9.PubMedPubMedCentralCrossRef
165.
Zurück zum Zitat Qaddoura A, Shalung TN, Meier MP, Goguen J, Jing R, Zhang S, et al. Recovery room cortisol predicts long-term glucocorticoid need after Transsphenoidal surgery for pituitary tumors. Neurosurgery. 2019;84(3):616–23.PubMedCrossRef Qaddoura A, Shalung TN, Meier MP, Goguen J, Jing R, Zhang S, et al. Recovery room cortisol predicts long-term glucocorticoid need after Transsphenoidal surgery for pituitary tumors. Neurosurgery. 2019;84(3):616–23.PubMedCrossRef
166.
Zurück zum Zitat Marko NF, Weil RJ. A comparative effectiveness analysis of alternative strategies to assess hypothalamic-pituitary-adrenal axis function after microsurgical resection of pituitary tumors. Neurosurgery. 2011;68(6):1576–84.PubMedCrossRef Marko NF, Weil RJ. A comparative effectiveness analysis of alternative strategies to assess hypothalamic-pituitary-adrenal axis function after microsurgical resection of pituitary tumors. Neurosurgery. 2011;68(6):1576–84.PubMedCrossRef
167.
Zurück zum Zitat Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, et al. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol. 2000b;53(4):431–6.CrossRef Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, et al. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clin Endocrinol. 2000b;53(4):431–6.CrossRef
168.
Zurück zum Zitat Jia X, Pendharkar AV, Loftus P, Dodd RL, Chu O, Fraenkel M, et al. Utility of a glucocorticoid sparing strategy in the management of patients following transsphenoidal surgery. Endocr Pract. 2016;22(9):1033–9.PubMedCrossRef Jia X, Pendharkar AV, Loftus P, Dodd RL, Chu O, Fraenkel M, et al. Utility of a glucocorticoid sparing strategy in the management of patients following transsphenoidal surgery. Endocr Pract. 2016;22(9):1033–9.PubMedCrossRef
169.
Zurück zum Zitat Sterl K, Thompson B, GossCW DRG, Rich KM, Zipfel GJ, et al. Withholding perioperative steroids in patients undergoing Transsphenoidal resection for pituitary disease: randomized prospective clinical trial to assess safety. Neurosurgery. 2019;85(2):E226–e32.PubMedCrossRef Sterl K, Thompson B, GossCW DRG, Rich KM, Zipfel GJ, et al. Withholding perioperative steroids in patients undergoing Transsphenoidal resection for pituitary disease: randomized prospective clinical trial to assess safety. Neurosurgery. 2019;85(2):E226–e32.PubMedCrossRef
170.
Zurück zum Zitat Prencipe N, Parasiliti-Caprino M, Gatti F, Penner F, Berton AM, Bona C, et al. Second day morning cortisol levels after transsphenoidal surgery are accurate predictors of secondary adrenal insufficiency with diagnostic cut-offs similar to non-stressed conditions. Neuroendocrinology. 2020. Prencipe N, Parasiliti-Caprino M, Gatti F, Penner F, Berton AM, Bona C, et al. Second day morning cortisol levels after transsphenoidal surgery are accurate predictors of secondary adrenal insufficiency with diagnostic cut-offs similar to non-stressed conditions. Neuroendocrinology. 2020.
171.
Zurück zum Zitat Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, et al. Age-related changes of the hypothalamic-pituitaryadrenal axis: pathophysiological correlates. Eur J Endocrinol. 2001;144(4):319–29.PubMedCrossRef Ferrari E, Cravello L, Muzzoni B, Casarotti D, Paltro M, Solerte SB, et al. Age-related changes of the hypothalamic-pituitaryadrenal axis: pathophysiological correlates. Eur J Endocrinol. 2001;144(4):319–29.PubMedCrossRef
172.
Zurück zum Zitat Elbuken G, Tanriverdi F, Karaca Z, Kula M, Gokahmetoglu S, Unluhizarci K, et al. Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers. Endocrine. 2015;48(2):439–43.PubMedCrossRef Elbuken G, Tanriverdi F, Karaca Z, Kula M, Gokahmetoglu S, Unluhizarci K, et al. Comparison of salivary and calculated free cortisol levels during low and standard dose of ACTH stimulation tests in healthy volunteers. Endocrine. 2015;48(2):439–43.PubMedCrossRef
173.
Zurück zum Zitat Roelfsema F, van Heemst D, IranmaneshA TP, Yang R, Veldhuis JD. Impact of age, sex and body mass index on cortisol secretion in 143 healthy adults. Endocr Connect. 2017;6(7):500–9.PubMedPubMedCentralCrossRef Roelfsema F, van Heemst D, IranmaneshA TP, Yang R, Veldhuis JD. Impact of age, sex and body mass index on cortisol secretion in 143 healthy adults. Endocr Connect. 2017;6(7):500–9.PubMedPubMedCentralCrossRef
Metadaten
Titel
Investigation of the Hypothalamo-pituitary-adrenal (HPA) axis: a contemporary synthesis
verfasst von
Zuleyha Karaca
Ashley Grossman
Fahrettin Kelestimur
Publikationsdatum
26.03.2021
Verlag
Springer US
Erschienen in
Reviews in Endocrine and Metabolic Disorders / Ausgabe 2/2021
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-020-09611-3

Weitere Artikel der Ausgabe 2/2021

Reviews in Endocrine and Metabolic Disorders 2/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.